1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Equine
Healthcare Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1.
By Product (Vaccines, Pharmaceuticals,
Medicinal Feed Additives, Diagnostics, Software & Services, Others)
5.2.2.
By Indication (Musculoskeletal Disorders, Parasite
Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine
Influenza, West Nile Virus, Tetanus, Others)
5.2.3.
By Activity (Sports/Racing, Recreation, Others)
5.2.4.
By Distribution Channel (Veterinary Hospitals &
Clinics, E-commerce, Others)
5.2.5. By
Region
5.2.6. By Company (2022)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Indication
5.3.3. By Activity
5.3.4. By Distribution Channel
5.3.5. By Region
6.
North America Equine
Healthcare Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1.
By Product (Vaccines, Pharmaceuticals, Medicinal Feed
Additives, Diagnostics, Software & Services, Others)
6.2.2.
By Indication (Musculoskeletal Disorders, Parasite
Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis,
Equine Influenza, West Nile Virus, Tetanus, Others)
6.2.3.
By Activity (Sports/Racing, Recreation, Others)
6.2.4. By Distribution Channel (Veterinary Hospitals
& Clinics, E-commerce, Others)
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Equine Healthcare Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share &
Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Indication
6.3.1.2.3.
By Activity
6.3.1.2.4.
By Distribution
Channel
6.3.2. Canada Equine Healthcare Market Outlook
6.3.2.1.
Market Size &
Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share &
Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Indication
6.3.2.2.3.
By Activity
6.3.2.2.4.
By Distribution
Channel
6.3.3. Mexico Equine Healthcare Market Outlook
6.3.3.1.
Market Size &
Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share &
Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Indication
6.3.3.2.3.
By Activity
6.3.3.2.4.
By Distribution
Channel
7.
Europe Equine
Healthcare Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1.
By Product (Vaccines, Pharmaceuticals, Medicinal Feed
Additives, Diagnostics, Software & Services, Others)
7.2.2.
By Indication (Musculoskeletal Disorders, Parasite
Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis,
Equine Influenza, West Nile Virus, Tetanus, Others)
7.2.3.
By Activity (Sports/Racing, Recreation, Others)
7.2.4. By Distribution Channel (Veterinary Hospitals
& Clinics, E-commerce, Others)
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Equine Healthcare Market Outlook
7.3.1.1.
Market Size &
Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share &
Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Indication
7.3.1.2.3.
By Activity
7.3.1.2.4.
By Distribution
Channel
7.3.2. United Kingdom Equine Healthcare Market Outlook
7.3.2.1.
Market Size &
Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share &
Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Indication
7.3.2.2.3.
By Activity
7.3.2.2.4.
By Distribution
Channel
7.3.3. France Equine Healthcare Market Outlook
7.3.3.1.
Market Size &
Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share &
Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Indication
7.3.3.2.3.
By Activity
7.3.3.2.4.
By Distribution
Channel
7.3.4. Italy Equine Healthcare Market Outlook
7.3.4.1.
Market Size &
Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share &
Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Indication
7.3.4.2.3.
By Activity
7.3.4.2.4.
By Distribution
Channel
7.3.5. Spain Equine Healthcare Market Outlook
7.3.5.1.
Market Size &
Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share &
Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Indication
7.3.5.2.3.
By Activity
7.3.5.2.4.
By Distribution
Channel
8.
Asia-Pacific Equine
Healthcare Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1.
By Product (Vaccines, Pharmaceuticals, Medicinal Feed
Additives, Diagnostics, Software & Services, Others)
8.2.2.
By Indication (Musculoskeletal Disorders, Parasite
Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis,
Equine Influenza, West Nile Virus, Tetanus, Others)
8.2.3.
By Activity (Sports/Racing, Recreation, Others)
8.2.4. By Distribution Channel (Veterinary Hospitals
& Clinics, E-commerce, Others)
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Equine Healthcare Market Outlook
8.3.1.1.
Market Size &
Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share &
Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Indication
8.3.1.2.3.
By Activity
8.3.1.2.4.
By Distribution
Channel
8.3.2. Japan Equine Healthcare Market Outlook
8.3.2.1.
Market Size &
Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share &
Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Indication
8.3.2.2.3.
By Activity
8.3.2.2.4.
By Distribution
Channel
8.3.3. India Equine Healthcare Market Outlook
8.3.3.1.
Market Size &
Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share &
Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Indication
8.3.3.2.3.
By Activity
8.3.3.2.4.
By Distribution
Channel
8.3.4. Australia Equine Healthcare Market Outlook
8.3.4.1.
Market Size &
Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share &
Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Indication
8.3.4.2.3.
By Activity
8.3.4.2.4.
By Distribution
Channel
8.3.5. South Korea Equine Healthcare Market Outlook
8.3.5.1.
Market Size &
Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share &
Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Indication
8.3.5.2.3.
By Activity
8.3.5.2.4.
By Distribution
Channel
9.
South America Equine
Healthcare Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1.
By Product (Vaccines, Pharmaceuticals, Medicinal Feed
Additives, Diagnostics, Software & Services, Others)
9.2.2.
By Indication (Musculoskeletal Disorders, Parasite
Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis,
Equine Influenza, West Nile Virus, Tetanus, Others)
9.2.3.
By Activity (Sports/Racing, Recreation, Others)
9.2.4. By Distribution Channel (Veterinary Hospitals
& Clinics, E-commerce, Others)
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Equine Healthcare Market Outlook
9.3.1.1.
Market Size &
Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share &
Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Indication
9.3.1.2.3.
By Activity
9.3.1.2.4.
By Distribution
Channel
9.3.2. Argentina Equine Healthcare Market Outlook
9.3.2.1.
Market Size &
Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share &
Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Indication
9.3.2.2.3.
By Activity
9.3.2.2.4.
By Distribution
Channel
9.3.3. Colombia Equine Healthcare Market Outlook
9.3.3.1.
Market Size &
Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share &
Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Indication
9.3.3.2.3.
By Activity
9.3.3.2.4.
By Distribution
Channel
10.
Middle East and
Africa Equine Healthcare Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1.
By Product (Vaccines, Pharmaceuticals, Medicinal Feed
Additives, Diagnostics, Software & Services, Others)
10.2.2.
By Indication (Musculoskeletal Disorders, Parasite
Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis,
Equine Influenza, West Nile Virus, Tetanus, Others)
10.2.3.
By Activity (Sports/Racing, Recreation, Others)
10.2.4. By Distribution Channel (Veterinary Hospitals
& Clinics, E-commerce, Others)
10.2.5. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Equine Healthcare Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Indication
10.3.1.2.3.
By Activity
10.3.1.2.4.
By Distribution
Channel
10.3.2. Saudi Arabia Equine Healthcare Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Indication
10.3.2.2.3.
By Activity
10.3.2.2.4.
By Distribution
Channel
10.3.3. UAE Equine Healthcare Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Indication
10.3.3.2.3.
By Activity
10.3.3.2.4.
By Distribution Channel
10.3.4. Kuwait Equine Healthcare Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Product
10.3.4.2.2.
By Indication
10.3.4.2.3.
By Activity
10.3.4.2.4.
By Distribution
Channel
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Porter’s Five Forces Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New
Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Products
14. Competitive Landscape
14.1.
Business Overview
14.2.
Product Offerings
14.3.
Recent Developments
14.4.
Financials (As Reported)
14.5.
Key Personnel
14.6.
SWOT Analysis
14.6.1. Zoetis Inc.
14.6.2. Boehringer Ingelheim
GmbH
14.6.3. Merck & Co.,
Inc.
14.6.4. Hallmarq Veterinary
Imaging Ltd
14.6.5. Esaote SpA
14.6.6. Vetoquinol SA
14.6.7. IDEXX Laboratories,
Inc.
14.6.8. Dechra
Pharmaceuticals PLC
15. Strategic Recommendations
16.
About Us & Disclaimer